MedPath

Optical Frequency Domain Imaging for Assessing Colonic Polyps

Not Applicable
Completed
Conditions
Colonic Polyps
Interventions
Device: MGH Optical Frequency Domain Imaging (OFDI) System
Registration Number
NCT01439087
Lead Sponsor
Massachusetts General Hospital
Brief Summary

The goal of this research is to conduct a pilot clinical study to image colonic polyps with the intent to evaluate the potential use of Optical Frequency Domain Imaging (OFDI) to identify the extent of invasion (if present), differentiate between hyperplastic polyps and adenomas, and identify serrated polyps.

Detailed Description

The colon OFDI catheter will be used in conjunction with a sigmoidoscope. If a sigmoid polyp is identified, the colonoscope will be removed and a sigmoidoscope inserted. The colon OFDI catheter will be advanced through the sigmoidoscope accessory port and positioned adjacent to the colon wall. Imaging will be performed with the OFDI system across the polyp's surface and the base/stalk if pedunculated. The investigators anticipate that on average the investigators will utilize 4 helical scans per polyp. Each of the scans will take less than 30 seconds.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
2
Inclusion Criteria
  • Patients undergoing a screening colonoscopy
  • Patients must be over the age of 18
  • Patient must be able to give informed consent
Exclusion Criteria
  • Patients with hemostasis disorders
  • Patients taking any anti-coagulants such as Coumadin or Plavix,

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
OFDI imagingMGH Optical Frequency Domain Imaging (OFDI) SystemOFDI imaging
Primary Outcome Measures
NameTimeMethod
Feasibility and Sensitivity of OFDI Imaging in the ColonDuring the OFDI imaging session which should take an average of 5 mintues

OFDI Images are analyzed and compared to standard of care biopsies in order to differentiate hyperplastic polyps from adenomas or to identify serrated polyps. A total of 15 subjects were consented, but upon inspection of the colon only 2 participants met the eligibility criteria and participated.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Massachusetts General Hospital

🇺🇸

Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath